4.7 Article

Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Beyond CGRP: The calcitonin peptide family as targets for migraine and pain

Tayla A. Rees et al.

Summary: In addition to CGRP, calcitonin family peptides may be therapeutically useful in treating migraines and other pain disorders. Their localization in peripheral pain pathways could play a role in migraines and pain.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Review Pharmacology & Pharmacy

Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene-related peptide family of peptides

Lars Edvinsson et al.

Summary: Migraine is a common neurological disorder affecting up to 15% of the global population. Recent pharmacological treatments targeting CGRP signaling molecules have provided safe and effective options for migraine patients, offering new hope for migraine therapy.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Review Medicine, General & Internal

Calcitonin gene-related peptide (CGRP) is a key molecule released in acute migraine attacks-Successful translation of basic science to clinical practice

Lars Edvinsson

Summary: Migraine is a common neurovascular disorder, affecting over 15% of the global population. Women are three times more likely to suffer from migraine compared to men. The underlying mechanisms of migraine are still largely unknown, but molecules such as CGRP play a crucial role in its pathophysiology.

JOURNAL OF INTERNAL MEDICINE (2022)

Review Clinical Neurology

Cardiovascular Disease and Migraine: Are the New Treatments Safe?

Jennifer Robblee et al.

Summary: The authors present data on the cardiovascular safety of new and old migraine treatments, finding that lasmiditan has no cardiovascular concerns and triptans may be safer than expected. The use of Gepants and CGRP mAbs in cardiovascular disease requires caution. More long-term data is needed and prescribers should inform patients of the limitations of current knowledge while offering effective and well-tolerated treatment options.

CURRENT PAIN AND HEADACHE REPORTS (2022)

Review Oncology

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy

Ramiro Vazquez et al.

Summary: The development and metastasis of solid tumors depend on the formation of blood and lymphatic vessels, known as angiogenesis and lymphangiogenesis, respectively. This process is mediated by specific growth-stimulating molecules like VEGF and AM secreted by various cell types, including those involved in tumor stroma. Anti-angiogenic therapy is a validated strategy in oncology, mainly targeting VEGF but limited by toxicity and acquired resistance. AM, a peptide hormone, plays a key role in blood vessel development and cardiovascular homeostasis, with potential as a therapeutic target in oncology.

FRONTIERS IN ONCOLOGY (2021)

Article Neurosciences

Neurokinins and their receptors in the rat trigeminal system: Differential localization and release with implications for migraine pain

Jacob C. A. Edvinsson et al.

Summary: Substance P (SP) and calcitonin gene-related peptide (CGRP) have been potential drug candidates in migraine therapy, with CGRP receptor inhibition established as an effective treatment. However, clinical trials showed that inhibition of neurokinin receptor 1 (NK1R) did not alleviate acute migraine attacks. Experimental results suggest that SP and CGRP may work together to exacerbate painful stimuli in the trigeminovascular system.

MOLECULAR PAIN (2021)

Article Biochemistry & Molecular Biology

Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion

Lars Edvinsson et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2020)

Review Biochemistry & Molecular Biology

Adrenomedullin - Current perspective on a peptide hormone with significant therapeutic potential

Jan-Patrick Fischer et al.

PEPTIDES (2020)

Review Clinical Neurology

Molecular studies of CGRP and the CGRP family of peptides in the central nervous system

Erica R. Hendrikse et al.

CEPHALALGIA (2019)

Article Cardiac & Cardiovascular Systems

Plasma endothelin-1 and adrenomedullin are associated with coronary artery function and cardiovascular outcomes in humans

James Theuerle et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)

Article Clinical Neurology

C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system

Jacob C. A. Edvinsson et al.

JOURNAL OF HEADACHE AND PAIN (2019)

Review Pharmacology & Pharmacy

New Insights into the Regulation of CGRP-Family Receptors

Joseph J. Gingell et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

Review Pharmacology & Pharmacy

CGRP/CGRP Receptor Antibodies: Potential Adverse Effects Due to Blockade of Neovascularization?

Masataka Majima et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

Article Clinical Neurology

Distribution of CGRP and CGRP receptor components in the rat brain

Karin Warfvinge et al.

CEPHALALGIA (2019)

Review Respiratory System

Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis

Kalina R. Atanasova et al.

RESPIRATORY RESEARCH (2018)

Review Pharmacology & Pharmacy

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

Debbie L. Hay et al.

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Article Ophthalmology

Distribution of CGRP and its receptor components CLR and RAMP1 in the rat retina

Frank W. Blixt et al.

EXPERIMENTAL EYE RESEARCH (2017)

Review Pharmacology & Pharmacy

Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles

Debbie L. Hay et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)

Article Agriculture, Dairy & Animal Science

Adrenomedullin regulates intestinal physiology and pathophysiology

S. Martinez-Herrero et al.

DOMESTIC ANIMAL ENDOCRINOLOGY (2016)

Article Endocrinology & Metabolism

Role of Amylin in Type 1 and Type 2 Diabetes

Laura Hieronymus et al.

DIABETES EDUCATOR (2015)

Review Pharmacology & Pharmacy

Amylin: Pharmacology, Physiology, and Clinical Potential

Debbie L. Hay et al.

PHARMACOLOGICAL REVIEWS (2015)

Article Immunology

Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels

Marta Pedreno et al.

BRAIN BEHAVIOR AND IMMUNITY (2014)

Review Physiology

CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY

F. A. Russell et al.

PHYSIOLOGICAL REVIEWS (2014)

Review Biochemistry & Molecular Biology

Modulation of immune responses by the neuropeptide CGRP

Bernhard Holzmann

AMINO ACIDS (2013)

Article Oncology

Adrenomedullin Blockade Suppresses Growth of Human Hormone-Independent Prostate Tumor Xenograft in Mice

Caroline Berenguer-Daize et al.

CLINICAL CANCER RESEARCH (2013)

Review Biotechnology & Applied Microbiology

Amylin Uncovered: A Review on the Polypeptide Responsible for Type II Diabetes

Karen Pillay et al.

BIOMED RESEARCH INTERNATIONAL (2013)

Review Pharmacology & Pharmacy

Pramlintide and the treatment of diabetes: a review of the data since its introduction

Lisa M. Younk et al.

EXPERT OPINION ON PHARMACOTHERAPY (2011)

Article Clinical Neurology

Possible sites of action of the new calcitonin gene-related peptide receptor antagonists

Sajedeh Eftekhari et al.

Therapeutic Advances in Neurological Disorders (2010)

Review Endocrinology & Metabolism

Salmon calcitonin: a review of current and future therapeutic indications

C. H. Chesnut et al.

OSTEOPOROSIS INTERNATIONAL (2008)

Article Oncology

Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion

Shereen Keleg et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

Article Endocrinology & Metabolism

Adrenomedullin inhibits insulin exocytosis via pertussis toxin-sensitive G protein-coupled mechanism

N Sekine et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)

Article Medicine, Research & Experimental

Tissue expression and plasma levels of adrenomedullin in renal cancer patients

Jens Michelsen et al.

CLINICAL SCIENCE (2006)

Article Developmental Biology

Calcitonin gene-related peptide stimulates human villous trophoblast cell differentiation in vitro

K. E. Green et al.

MOLECULAR HUMAN REPRODUCTION (2006)

Article Endocrinology & Metabolism

Adrenomedullin is a novel marker of tumor progression in neuroendocrine carcinomas

ME Pavel et al.

HORMONE AND METABOLIC RESEARCH (2006)

Article Endocrinology & Metabolism

Amylin agonists: A novel approach in the treatment of diabetes

O Schmitz et al.

DIABETES (2004)

Article Cardiac & Cardiovascular Systems

Involvement of calcitonin gene-related peptide in control of human fetoplacental vascular tone

YL Dong et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)

Review Pharmacology & Pharmacy

Calcitonin gene-related peptide: role in airway homeostasis

A Dakhama et al.

CURRENT OPINION IN PHARMACOLOGY (2004)

Article Pharmacology & Pharmacy

Mechanism of CGRP-induced vasodilation in the rat isolated perfused kidney

I Ay et al.

PHARMACOLOGY (2004)

Review Endocrinology & Metabolism

Adrenomedullin and cancer

E Zudaire et al.

REGULATORY PEPTIDES (2003)

Article Endocrinology & Metabolism

Somatostatin receptor subtypes in human pheochromocytoma: Subcellular expression pattern and functional relevance for octreotide scintigraphy

J Mundschenk et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)

Article Endocrinology & Metabolism

Adrenomedullin, a new peptide, in patients with insulinoma

C Letizia et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)

Article Peripheral Vascular Disease

Effect of adrenomedullin on placental arteries in normal and preeclamptic pregnancies

S Jerat et al.

HYPERTENSION (2001)

Article Developmental Biology

Expression of the adrenomedullin gene in epithelial ovarian cancer

K Hata et al.

MOLECULAR HUMAN REPRODUCTION (2000)